Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kao Shi
Observed names:
K S Shi,
Keying Shi
Institution:
Zhejiang Chinese Medical University
Observed institution:
Zhejiang Chinese Medical University
ORCID:
0009-0000-1153-0507
Observed ORCID:
0009-0000-1153-0507
OpenAlex ID:
A5027509168
SIRT3: A potential therapeutic target for liver fibrosis
2024
·
Yan Ning
, Xinyue Dou
, et al.
·
Pharmacology & Therapeutics
·
50
Targeting AKT to treat liver disease: Opportunities and challenges
2025
·
Zeping Wang
, Xinyue Dou
, et al.
·
Biochemical Pharmacology
·
15
Taxifolin attenuates liver fibrosis by regulating the phosphorylation of NDRG1 at Thr328 via hepatocyte-stellate cell cross talk
2025
·
Chuan Ding
, Zeping Wang
, et al.
·
Acta Pharmaceutica Sinica B
·
14
Cornus officinalis with high pressure wine steaming enhanced anti-hepatic fibrosis: Possible through SIRT3-AMPK axis
2023
·
Xin Han
, Yan Ning
, et al.
·
Journal of Pharmaceutical Analysis
·
13
Human umbilical cord-derived mesenchymal stem cells/Bio-Oss granules composite prevents medication-related osteonecrosis of the jaw in a rat model
2026
·
Zhi Chen
, Keying Shi
, et al.
·
Frontiers in Bioengineering and Biotechnology
·
1
PDF
[Expression of cyclin Y in hepatocellular carcinoma cells and its correlation with clinical characteristics of hepatocellular carcinoma patients].
2018
·
K S Shi
, C L Tang
, et al.
·
PubMed
Show more works
View as search
Works count:
6
Citation count:
93
H-index:
4
I10-index:
4
Year
Topic
Type